Glaxo-SmithKline is publishing details of 13,500 chemical compounds from its own library that have potential to act against the parasite that causes malaria in sub-Saharan Africa, killing at least one million children every year.
It took a team of five investigators a year to screen the two million compounds in GSK's library � its entire collection of potential drugs and possibly the biggest such library in the world.
Chief executive Andrew Witty also announced an $8m fund to pay for scientists to explore these chemicals or others in an "open lab" within its research centre at Tres Cantos, Spain, which is dedicated to work on malaria and other diseases of the developing world.
"The ultimate test of a moral society is the kind of world that it leaves to its children." - Dietrich Bonhoeffer